Login to Your Account

MGI Sells Dacogen Rights Ex-North America To Cilag

By Karen Pihl-Carey

Friday, July 7, 2006
Two months after receiving FDA approval for Dacogen to treat myelodysplastic syndromes, MGI Pharma Inc. licensed rights to the drug outside North America to Cilag GmbH. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription